Metsera operates a clinical-stage biopharmaceutical company that offers oral and injectable incretin, non-incretin, and combination therapies with potential profiles to address multiple therapeutic targets, enabling users to meet the future needs of a rapidly evolving weight loss treatment landscape. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $290M, Series A

Round Investors: ARCH Venture Partners (lead), F-Prime Capital, Google Ventures, Mubadala Capital Ventures

🚀Growth Focus: Expand operations and its R&D sector to prepare for commercialization.

Press: Fierce Biotech, BioSpace

HQ: New York, NY

Industry: Biotechnology Research

Employee Count: 10

Clazar provides a cloud go-to-market platform that helps software companies manage their listings, private offers, contracts, metering records, and more across all-in-one cloud marketplaces, allowing clients to track their performance and optimize their sales strategy. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $10M, Series A

Round Investors: DST Global (lead), Ensemble VC (lead), Ridge Ventures (lead), Twin Ventures

🚀Growth Focus: Invest further in R&D and product innovation, helping it continue to expand offerings alongside a rapidly growing customer base and meet its demands.

Press: VentureBeat, Business Wire

HQ: San Francisco, CA

Industry: Software Development

Employee Count: 41 (⚡64% increase in last 6 months)